Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F.C. McDuffie.
Morbility impact of rheumatoid arthritis on society.
Am J Med, 78 (1985), pp. 1-5
[2.]
P. Reilly, J. Cosh, P. Maddison, J. Rasker, A. Silman.
Mortality and survival in rheumatoid arthritis: a 25 years prospective study of 100 patients.
Ann Rheum Dis, 49 (1990), pp. 363-369
[3.]
T. Pincus, R. Brooks, L. Callahan.
Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaires and joint count measures.
Ann Intern Med, 120 (1994), pp. 26-34
[4.]
J.A. Markenson.
Worlwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis.
Semin Arthritis Rheum, 21 (1991), pp. 4-12
[5.]
S. Cobbs, F. Anderson, W. Bauer.
Length of life and cause of death in rheumatoid arthritis.
N Engl J Med, 249 (1953), pp. 553-556
[6.]
E. Bywaters, M. Curwen, E. Dresner, A. Dixon.
Ten years follow-up of rheumatoid arthritis.
Ann Rheum Dis, 20 (1961), pp. 198-199
[7.]
J. Duthie, P. Brown, L. Truelove, F. Baragar, A. Lawrie.
Course and prognosis in rheumatoid arthritis: a further report.
Ann Rheum Dis, 23 (1964), pp. 193-204
[8.]
D. Scott, D. Symmons, B. Coulton, A. Popert.
Long-term outcome of treating rheumatoid arthritis: results after 20 years.
Lancet, 1 (1987), pp. 1108-1111
[9.]
G. Moesmann.
Malignancy and mortality in subacute rheumatoid arthritis in old age.
Acta Rheuma Scand, 15 (1969), pp. 193-199
[10.]
J. Uddin, A. Kraus, H. Kelly.
Survivorship and death in rheumatoid arthritis.
Arthritis Rheum, 13 (1970), pp. 125-130
[11.]
H. Isomäki, O. Mutru, K. Koota.
Death rate and causes of death in patients with rheumatoid arthritis.
Scand J Rheumatol, 4 (1975), pp. 205-208
[12.]
K. Koota, H. Isomäki, O. Mutru.
Death rate and causes of death in RA patients during a period of five years.
Scand J Rheumatol, 6 (1977), pp. 241-244
[13.]
J. Rasker, J. Cosh.
Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis.
Ann Rheum Dis, 40 (1981), pp. 115-120
[14.]
P. Allebeck.
Increased mortality in rheumatoid arthritis.
Scand J Rheumatol, 11 (1982), pp. 81-86
[15.]
P. Prior, D. Symmons, D. Scott, R. Brown, C. Hawkins.
Cause of death in rheumatoid arthritis.
Br J Rheumatol, 23 (1984), pp. 92-99
[16.]
J. Vandenbroucke, H. Hazevoet, A. Cats.
Survival and cause of death in rheumatoid arthritis: a 25 year prospective follow-up.
J Rheumatol, 11 (1984), pp. 158-161
[17.]
O. Mutru, M. Laakso, H. Isomäki, K. Koota.
Ten year mortality and causes of death in patients with rheumatoid arthritis.
Br Med J, 290 (1985), pp. 1797-1799
[18.]
J. Fries, D. Bloch, P. Spitz, D. Mitchell.
Cancer in rheumatoid arthritis: a prospective long-term study of mortality.
Am J Med, 78 (1985), pp. 56-59
[19.]
D. Mitchell, P. Spitz, D. Young, D. Bloch, D. McShane, J. Fries.
Survival, prognosis, and causes of death in rheumatoid arthritis.
Arthritis Rheum, 29 (1986), pp. 706-714
[20.]
L. Jacobsson, W. Knowler, S. Pillemar, R. Hanson, D. Petitt, R. Nelson, et al.
Rheumatoid arthritis and mortality: a longitudinal study in Pima indians.
Arthritis Rheum, 36 (1993), pp. 1045-1053
[21.]
F. Wolfe, D. Mitchell, J. Sibley, J. Fries, D. Bloch, C. Williams, et al.
The mortality of rheumatoid arthritis.
Arthritis Rheum, 37 (1994), pp. 481-494
[22.]
R. Myllykangas-Luosujärvi, K. Aho, H. Kautiainen, H. Isomäki.
Cardiovascular mortality in women with rheumatoid arthritis.
J Rheumatol, 22 (1995), pp. 1065-1067
[23.]
S. Wallberg-Jonsson, M. Öhman, S. Dahlqvist.
Cardiovascular morbility and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
J Rheumatol, 24 (1997), pp. 445-451
[24.]
D. Symmons, M. Jones, D. Scott, P. Prior.
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.
J Rheumatol, 25 (1998), pp. 1072-1077
[25.]
S. Gabriel, C. Crowson, W. O’Fallon.
Mortality in Rheumatoid Arthritis: have we made an impact in 4 decades.
J Rheumatol, 26 (1999), pp. 2529-2533
[26.]
A. Linos, J. Worthington, W. O’Fallon, L. Kurland.
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.
Am J Epidemiol, 111 (1980), pp. 87-98
[27.]
I. Wicks, J. Moore, A. Fleming.
Australian mortality statistics for rheumatoid arthritis 1950-81: analysis of death certificate data.
Ann Rheum Dis, 47 (1988), pp. 563-569
[28.]
E. Lindqvist, K. Eberhardt.
Mortality in rheumatoid arthritis patients with disease onset in the 1980.
Ann Rheum Dis, 58 (1999), pp. 11-14
[29.]
L. Kazis, J. Anderson, R. Meenan.
Health status as a predictor of mortality in rheumatoid arthritis: a five year study.
J Rheumatol, 17 (1990), pp. 609-613
[30.]
J. Leigh, J. Fries.
Mortality predictors among 263 patients with rheumatoid arthritis.
J Rheumatol, 18 (1991), pp. 1307-1312
[31.]
K. Lehtinen, H. Isomäki.
Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis.
J Rheumatol, 18 (1991), pp. 524-529
[32.]
T. Pincus, L. Callahan.
Rheumatology function tests: grip strength, walking time, button test and questionnaries document and predict longterm morbility and mortality in rheumatoid arthritis.
J Rheumatol, 19 (1992), pp. 1051-1057
[33.]
A. Suzuki, Y. Ohosone, M. Obana, S. Mita, Y. Matsuoka, S. Inmajisi, et al.
Cause of death in 81 autopsied patients with rheumatoid arthritis.
J Rheumatol, 21 (1994), pp. 33-36
[34.]
C. Erhardt, P. Mumford, P. Venables, R. Maini.
Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study.
Ann Rheum Dis, 48 (1989), pp. 7-13
[35.]
P. Allebeck, Y. Rodvall, E. Allander.
Mortality in rheumatoid arthritis, particulary as regards drug use.
Scand J Rheumatol, 14 (1985), pp. 102-108
[36.]
S. Wallberg-Jonsson, H. Johansson, M. Öhman, S. Rantapää-Dalhlqvist.
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis.
J Rheumatol, 26 (1999), pp. 2562-2571
[37.]
Dougall R Mc, J. Sibley, M. Haga, A. Russell.
Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls.
J Rheumatol, 21 (1994), pp. 1207-1213
[38.]
S. Rössner, C. Löfmark.
Dyslipoproteinaemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance.
Atherosclerosis, 28 (1977), pp. 41-52
[39.]
K. Svenson, H. Lithell, R. Hällgren, B. Vessby.
Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritis.
Arch Intern Med, 147 (1987), pp. 1917-1920
[40.]
K. Svenson, H. Lithell, R. Hällgren, I. Selinus, B. Vessby.
Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritis.
Arch Intern Med, 147 (1987), pp. 1912-1916
[41.]
M. Lazarevic, J. Vitic, V. Mladenovic, B. Myones, J. Skosey, W. Swedler.
Dyslipopreteinemia in the course of active rheumatoid arthritis.
Semin Arthritis Rheum, 22 (1992), pp. 172-180
[42.]
S. Rantapää-Dahlqvist, S. Wallerberg-Jonsson, G. Dahlén.
Lipoprotein (a), lipids, and lipoproteins in patientes with rheumatoid arthritis.
Ann Rheum Dis, 50 (1991), pp. 366-368
[43.]
Y. Asanuma, S. Kawai, H. Aoshima, J. Kaburaki, Y. Mizushima.
Serum lipoprotein (a) and apolipoprotein (a) phenotypes in patients with rheumathoid arthritis.
Arthritis Rheum, 42 (1999), pp. 443-447
[44.]
Y.B. Park, S.K. Lee, W.K. Lee, et al.
Lipid profiles in untreated patients with rheumatoid arthritis.
J Rheumatol, 26 (1999), pp. 1701-1704
[45.]
G. Dahlén.
Lp(a) lipoprotein in cardiovascular disease.
Atherosclerosis, 108 (1994), pp. 111-126
[46.]
M. Selly, D. Bourne, M. Bartlett, K. Tymmus, A. Book, A. Duffeld, et al.
Occurence of 4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis.
Ann Rheum Dis, 51 (1992), pp. 481-484
[47.]
R. Disilvestro, J. Marten, M. Skehan.
Effects of copper supplementation on ceruloplasmin and copper-zinc superoxide dismutase in free living rheumatoid arthritis patients.
J Am Nutr, 11 (1992), pp. 177-180
[48.]
T. Vijayalakshmi, V. Muthulakshmi, P. Sachdanandam.
Salubrious effect of semecarpus anacardium against lipid peroxidative changes in adjuvant arthritis studied in rats.
Mol Cell Biochem, 175 (1997), pp. 65-69
[49.]
P. Winyard, F. Tatzber, H. Esterbauter, M. Kus, D. Blake, C. Morris.
Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis.
Ann Rheum Dis, 52 (1993), pp. 677-680
[50.]
R. Roubenoff, P. Dellaripa, M. Nadeau, L. Abad, B. Muldoon, J. Selhub, et al.
Abnormal homocysteine metabolism in rheumatoid arthritis.
Arthritis Rheum, 40 (1997), pp. 718-722
[51.]
R. Clarke, L. Daly, K. Robinson, E. Naughten, S. Cahalane, B. Fowler, et al.
Hyperhomocysteinemia: an independent risk factor for vascular disease.
N Engl J Med, 324 (1991), pp. 1149-1155
[52.]
O. Nygard, J. Nordrehaung, H. Refsum, M. Ueland, M. Farstad, S. Vollset.
Plasma homocysteine levels and mortality in patients with coronary artery disease.
N Engl J Med, 337 (1997), pp. 230-236
[53.]
Albada-Kuipers G Van, J. Brujn, M. Westedt, F. Breedveld, F. Eulderink.
Coronary arteritis complicating rheumatoid arthritis.
Ann Rheum Dis, 45 (1986), pp. 963-965
[54.]
I. Karten.
Arteritis, myocardial infarction and rheumatoid arthritis.
JAMA, 210 (1969), pp. 1717-1720
[55.]
W. Voyles, R. Searles, A. Bankhurst.
Myocardial infarction caused by rheumatoid vasculitis.
Arthritis Rheum, 23 (1980), pp. 860-863
[56.]
P. Morris, M. Imber, J. Heinsimer, M. Hlatky, K. Reimer.
Rheumatoid arthritis and coronary arteritis.
Am J Cardiol, 57 (1986), pp. 689-690
[57.]
R. Swezey.
Myocardial infarction due to rheumatoid arthritis.
JAMA, 199 (1967), pp. 855-857
[58.]
G. Alarcon, I. Tracy, G. Strand, K. Singh, M. Macaluso.
Survival and drug discontinuation in a large cohort of methotrexate treated rheumatoid arthritis patients.
Ann Rheum Dis, 54 (1995), pp. 708-712
[59.]
R. Myllykangas-Luosujärvi, K. Aho, H. Isomäki.
Death attributed to antirheumatic medication in a Nationwide series of 1666 patients with rheumatoid arthritis who have died.
J Rheumatol, 22 (1995), pp. 2214-2217
[60.]
P. Allebeck, A. Ahlbom, E. Allander.
Increased mortality among persons with rheumatoid arthritis, but where rheumatoid arthritis does not appear on the death certificate.
Scand J Rheumtol, 10 (1981), pp. 301
[61.]
P. Lewis, B. Hazleman, R. Hanka, S. Roberts.
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.
Ann Rheum Dis, 39 (1980), pp. 457-461
[62.]
M. Laakso, O. Mutru, H. Isomäki, K. Koota.
Cancer mortality in patients with rheumatoid arthritis.
J Rheumatol, 13 (1986), pp. 522-526
[64.]
T. Hakulinen, H. Isomaki, P. Knekt.
Rheumatoid arthritis and cancer studies based on linking Nationwide registries in Finland.
Am J Med, 78 (1985), pp. 29-32
Copyright © 2001. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.